135
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

rs10490924 surrounding HTRA1/ARMS2 regulates the susceptibility of age-related macular degeneration

, , , , , & show all
Pages 188-195 | Received 22 Oct 2019, Accepted 31 Jul 2020, Published online: 10 Aug 2020

References

  • Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122(4):564–572.
  • Xu L, Li YB, Wang YX, et al. Age-related macular degeneration and mortality: the Beijing eye study. Ophthalmologica. 2008;222(6):378–379.
  • Horie-Inoue K, Inoue S. Genomic aspects of age-related macular degeneration. Biochem Biophys Res Commun. 2014;452(2):263–275.
  • Khanamiri HN, Falavarjani KG, Sanati MH, et al. Complement factor H Y402H and LOC387715 A69S polymorphisms in association with age-related macular degeneration in Iran. J Ophthal Vision Res. 2014;9(2):181.
  • Fritsche LG, Loenhardt T, Janssen A, et al. Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat Genet. 2008;40(7):892–896.
  • Francis PJ, Zhang H, DeWan A, et al. Joint effects of polymorphisms in the HTRA1, LOC387715/ARMS2, and CFH genes on AMD in a Caucasian population. Mol Vision. 2008;14:1395.
  • Yang Z, Camp NJ, Sun H, et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science. 2006;314(5801):992–993.
  • Nakayama M, Iejima D, Akahori M, et al. Overexpression of HtrA1 and exposure to mainstream cigarette smoke leads to choroidal neovascularization and subretinal deposits in aged mice. Invest Ophthalmol Vis Sci. 2014;55(10):6514–6523.
  • Jones A, Kumar S, Zhang N, et al. Increased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice. Proc Natl Acad Sci USA. 2011;108(35):14578–14583.
  • Vierkotten S, Muether PS, Fauser S. Overexpression of HTRA1 leads to ultrastructural changes in the elastic layer of Bruch's membrane via cleavage of extracellular matrix components. PLoS One. 2011;6(8):e22959.
  • Almeida LN, Melilo-Carolino R, Veloso CE, et al. Association analysis of CFH and ARMS2 gene polymorphisms in a Brazilian cohort with age-related macular degeneration. Ophthalmic Res. 2013;50(2):117–122.
  • Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol. 1988;32(6):375–413.
  • Gotoh N, Nakanishi H, Hayashi H, et al. ARMS2 (LOC387715) variants in Japanese patients with exudative age-related macular degeneration and polypoidal choroidal vasculopathy. Am J Ophthalmol. 2009;147(6):1037–1041.
  • Jakobsdottir J, Conley YP, Weeks DE, et al. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet. 2005;77(3):389–407.
  • Kanda A, Chen W, Othman M, et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci USA. 2007;104(41):16227–16232.
  • Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443(7113):787–795.
  • Pulido JS, Peterson LM, Mutapcic L, et al. LOC387715/HTRA1 and complement factor H variants in patients with age-related macular degeneration seen at the mayo clinic. Ophthalmic Genet. 2007;28(4):203–207.
  • Rivera A, Fisher SA, Fritsche LG, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet. 2005;14(21):3227–3236.
  • Scholl HP, Fleckenstein M, Issa PC, et al. An update on the genetics of age-related macular degeneration. Mol Vision. 2007;13:196.
  • Spencer KL, Hauser MA, Olson LM, et al. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum Mol Genet. 2007;16(16):1986–1992.
  • Wang G, Scott WK, Agarwal A, et al. Coding variants in ARMS2 and the risk of age-related macular degeneration. JAMA Ophthalmol. 2013;131(6):804–805.
  • Wang G, Spencer KL, Scott WK, et al. Analysis of the indel at the ARMS2 3'UTR in age-related macular degeneration. Hum Genet. 2010;127(5):595–602.
  • Wang D, Zhou J, Hou X, et al. CETP gene may be associated with advanced age-related macular degeneration in the chinese population. Ophthalmic Genet. 2014;36(4):303–308.
  • Zhou J, Wang D, Zhang J, et al. RAD51 gene is associated with advanced age-related macular degeneration in Chinese population. Clin Biochem. 2013;46(16–17):1689–1693.
  • Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
  • Higgins J, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558.
  • DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
  • Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
  • Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101.
  • Seddon JM, Gensler G, Rosner B. C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration. Ophthalmology. 2010;117(8):1560–1566.
  • Leveziel N, Souied EH, Richard F, et al. PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population. Mol Vis. 2007;13:2153–2159.
  • Chowers I, Meir T, Lederman M, et al. Sequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel. Mol Vision. 2008;14:2263.
  • Zerbib J, Delcourt C, Puche N, et al. Risk factors for exudative age-related macular degeneration in a large French case–control study. Graefe Arch Clin Exp Ophthalmol. 2014;252(6):899–907.
  • Fourgeux C, Dugas B, Richard F, et al. Single nucleotide polymorphism in the cholesterol-24S-hydroxylase (CYP46A1) gene and its association with CFH and LOC387715 gene polymorphisms in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2012;53(11):7026–7033.
  • Tanaka K, Nakayama T, Yuzawa M, et al. Analysis of candidate genes for age-related macular degeneration subtypes in the Japanese population. Mol Vis. 2011;17:2751–2758.
  • Kaur I, Katta S, Hussain A, et al. Variants in the 10q26 gene cluster (LOC387715 and HTRA1) exhibit enhanced risk of age-related macular degeneration along with CFH in Indian patients. Invest Ophthalmol Vis Sci. 2008;49(5):1771–1776.
  • Xu Y, Guan N, Xu J, et al. Association of CFH, LOC387715, and HTRA1 polymorphisms with exudative age-related macular degeneration in a northern Chinese population. Mol Vision. 2008;14:1373.
  • Hirata FE, Vasconcellos JPCd, Medina FM, et al. Association of LOC387715/ARMS2 (rs10490924) gene polymorphism with age-related macular degeneration in the Brazilian population. Ophthalmic Genet. 2015; 36(3):224–225.
  • Kaur I, Cantsilieris S, Katta S, et al. Association of the del443ins54 at the ARMS2 locus in Indian and Australian cohorts with age-related macular degeneration. Mol Vision. 2013;19:822.
  • Oka C, Tsujimoto R, Kajikawa M, et al. HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins. Development. 2004;131(5):1041–1053.131].
  • Grau S, Richards PJ, Kerr B, et al. The role of human HtrA1 in arthritic disease. J Biol Chem. 2006;281(10):6124–6129.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.